ArticleCancer research2020

Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.

Suman Mukhopadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.